Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
J. Fernando Arevalo, Andres F. Lasave, Vishali Gupta, Igor Kozak, Mosa Barakat Al Harbi, Abdulaziz Adel Al Rushood & Hassan A. Al Dhibi. (2016) Clinical Outcomes of Patients with Vogt–Koyanagi–Harada Disease Over 12 Years at a Tertiary Center. Ocular Immunology and Inflammation 24:5, pages 521-529.
Read now
Read now
Kyungmin Lee, Asima Bajwa, Clovis A Freitas-Neto, Jamie Lynne Metzinger, Bailey A Wentworth & C Stephen Foster. (2014) A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I. Expert Opinion on Pharmacotherapy 15:15, pages 2141-2154.
Read now
Read now
Pinar Ozdal, Yasemin Ozdamar, Alper Yazici, Mehmet Y. Teke & Faruk Ozturk. (2014) Vogt-Koyanagi-Harada Disease: Clinical and Demographic Characteristics of Patients in a Specialized Eye Hospital in Turkey. Ocular Immunology and Inflammation 22:4, pages 277-286.
Read now
Read now
Denis Wakefield. (2014) Does Cyclophosphamide Still Have a Role in the Treatment of Severe Inflammatory Eye Disease?. Ocular Immunology and Inflammation 22:4, pages 306-310.
Read now
Read now
Articles from other publishers (9)
Zhenyu Zhong, Lingyu Dai, Qiuying Wu, Yu Gao, Yanlin Pu, Guannan Su, Xiaorong Lu, Fuxiang Zhang, Chong Tang, Yao Wang, Chunjiang Zhou & Peizeng Yang. (2023) A randomized non-inferiority trial of therapeutic strategy with immunosuppressants versus biologics for Vogt-Koyanagi-Harada disease. Nature Communications 14:1.
Crossref
Crossref
Ioannis Papasavvas, Ilknur Tugal-Tutkun & Carl P. HerbortJr.Jr.. (2022) Mechanisms, Pathophysiology and Current Immunomodulatory/Immunosuppressive Therapy of Non-Infectious and/or Immune-Mediated Choroiditis. Pharmaceuticals 15:4, pages 398.
Crossref
Crossref
Ana Belen Rivas, Amanda Lopez-Picado, Valentina Calamia, Ester Carreño, Lidia Cocho, Miguel Cordero-Coma, Alex Fonollosa, Felix M Francisco Hernandez, Angel Garcia-Aparicio, Javier Garcia-Gonzalez, Jose Juan Mondejar, Leticia Lojo-Oliveira, Llucí Martínez-Costa, Santiago Munoz, Diana Peiteado, Jose Antonio Pinto, Beatriz Rodriguez-Lozano, Esperanza Pato, David Diaz-Valle, Elena Molina, Luis Alberto Tebar & Luis Rodriguez-Rodriguez. (2022) Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study. BMJ Open 12:3, pages e051378.
Crossref
Crossref
H. Nida Sen. 2020. Whitcup and Nussenblatt's Uveitis. Whitcup and Nussenblatt's Uveitis
296
309
.
Emily Su, Vikash S. Oza & Paul Latkany. (2019) A case of recalcitrant pediatric Vogt-Koyanagi-Harada disease successfully controlled with adalimumab. Journal of the Formosan Medical Association 118:5, pages 945-950.
Crossref
Crossref
John A. Gonzales. 2019. Treatment of Non-infectious Uveitis. Treatment of Non-infectious Uveitis
27
44
.
John A. Gonzales & Nisha Acharya. 2019. Posterior Uveitis. Posterior Uveitis
175
207
.
Carl P. Herbort Jr, Ahmed M. Abu El Asrar, Joyce H. Yamamoto, Carlos E. Pavésio, Vishali Gupta, Moncef Khairallah, Ilknur Tugal-Tutkun, Masoud Soheilian, Masuru Takeuchi & Marina Papadia. (2016) Reappraisal of the management of Vogt–Koyanagi–Harada disease: sunset glow fundus is no more a fatality. International Ophthalmology 37:6, pages 1383-1395.
Crossref
Crossref
Elizabeth Shen, Sivakumar R. Rathinam, Manohar Babu, Anuradha Kanakath, Radhika Thundikandy, Salena M. Lee, Erica N. Browne, Travis C. Porco & Nisha R. Acharya. (2016) Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies. American Journal of Ophthalmology 168, pages 279-286.
Crossref
Crossref